Hardik Parikh
Stock Analyst at JP Morgan
(n/a)
# 4,724
Out of 5,139 analysts
6
Total ratings
n/a
Success rate
-48.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Hardik Parikh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Overweight | $65 → $105 | $67.47 | +55.62% | 2 | Jan 22, 2026 | |
| VKTX Viking Therapeutics | Maintains: Overweight | $80 → $75 | $31.10 | +141.16% | 2 | Oct 24, 2025 | |
| PCRX Pacira BioSciences | Downgrades: Underweight | $45 → $10 | $23.18 | -56.86% | 2 | Aug 12, 2024 |
Structure Therapeutics
Jan 22, 2026
Maintains: Overweight
Price Target: $65 → $105
Current: $67.47
Upside: +55.62%
Viking Therapeutics
Oct 24, 2025
Maintains: Overweight
Price Target: $80 → $75
Current: $31.10
Upside: +141.16%
Pacira BioSciences
Aug 12, 2024
Downgrades: Underweight
Price Target: $45 → $10
Current: $23.18
Upside: -56.86%